Becoming a Company with a Strong Global Presence and Achieving Sustainable, Profitable, High-Quality Growth
First written in FY2016. 19 of 39 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-08-07.
The whole theme swung hardest in 2025: 6 of 27 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- 2026-08-07AdvancedEarnings
「Revenue increased 19.9% year on year to ¥311.8 billion.」
The increase in revenue and adjusted operating profit in the first quarter indicated progress toward sustainable, profitable growth. - FY2026Partially missed the targetAnnual report
「The consolidated results for the current fiscal year, the fourth year of the five-year growth strategy, are as follows.」
In the final year of GS26, revenue was ¥1,131.9 billion, up 9.2% year on year, and adjusted operating profit was ¥219.4 billion, up 7.8%. While revenue growth progressed, operating margin was approximately 15.6%, ROIC was 7.5% and ROE was 9.2%, so the targets of an operating margin of at least 20%, ROIC of at least 10% and ROE of at least 10% were not achieved. - FY2026-H1AdvancedAnnual report
「Revenue was ¥534.9 billion, up 5.2% year on year. Adjusted operating profit increased 10.0% to ¥114.4 billion, driven by factors including the increase in gross profit.」
In FY2026-H1, revenue increased 5.2% year on year and adjusted operating profit increased 10.0%, demonstrating progress toward sustainable, profitable growth. - FY2025AdvancedAnnual report
「The consolidated results for the fiscal year, the third year of the five-year growth strategy, were as follows.」
In the third year of GS26, revenue increased 12.4% year on year and adjusted operating profit increased 29.8%. Operating margin was approximately 15.2%, adjusted operating margin approximately 19.6%, ROIC 7.5% and ROE 8.7%. While revenue growth progressed, the targets of an operating margin of at least 20%, ROIC of at least 10% and ROE of at least 10% were not achieved. - FY2025-H1AdvancedAnnual report
「Revenue was ¥508.7 billion, up 14.6% year on year. Adjusted operating profit increased 37.6% to ¥104.0 billion, driven by the increase in gross profit.」
Revenue and profit increased in the interim consolidated accounting period, with revenue up 14.6% year on year and adjusted operating profit up 37.6%. Performance related to sustainable, profitable growth improved. - FY2024AdvancedAnnual report
「In December 2021, the Group formulated a growth strategy covering the next five years and set the following targets for growth, profitability and efficiency, working toward achieving them. Targets: Growth: revenue growth in the high-single digits; Profitability: operating margin of at least 20%; Capital efficiency: maintain ROIC of at least 10% and ROE of at least 10%.」
While continuing to pursue the GS26 targets, FY2024 revenue increased 12.4% year on year and adjusted operating profit increased 13.6%. Operating margin was approximately 17.0%, ROIC was 7.1% and ROE was 8.7%, demonstrating growth, but the disclosed targets for operating margin, ROIC and ROE were not achieved. - FY2024-Q3AdvancedAnnual report
「Revenue was ¥683.0 billion, up 10.5% year on year. Adjusted operating profit increased 9.2% to ¥119.7 billion, as the increase in gross profit more than offset the increase in selling, general and administrative expenses.」
For the nine months ended December of FY2024, revenue increased 10.5% year on year and adjusted operating profit increased 9.2%, with progress toward sustainable, profitable growth continuing. - FY2024-Q2AdvancedAnnual report
「Revenue was ¥443.9 billion, up 10.1% year on year. Adjusted operating profit increased 7.3% to ¥75.6 billion, as the increase in gross profit more than offset the increase in selling, general and administrative expenses.」
In the six months ended September of FY2024, revenue increased 10.1% year on year and adjusted operating profit increased 7.3%, turning from revenue growth and a decline in adjusted operating profit in FY2024-Q1 to growth in both revenue and profit. - FY2024-Q1Revenue growth, decline in adjusted operating profitAnnual report
「Revenue was ¥215.3 billion, up 9.1% year on year. Adjusted operating profit fell 3.9% to ¥34.5 billion, as selling, general and administrative expenses increased because of stepped-up investment in growth areas.」
In FY2024-Q1, revenue increased 9.1% year on year, while adjusted operating profit fell 3.9% as selling, general and administrative expenses increased due to stepped-up investment in growth areas. - FY2023AdvancedAnnual report
「Revenue was ¥820.2 billion, up 16.6% year on year. Adjusted operating profit increased 2.7% to ¥138.0 billion.」
In FY2023, revenue increased 16.6%, adjusted operating profit increased 2.7% and operating profit increased 1.2%. Profit growth remained modest relative to revenue growth. - FY2023-Q3Revenue growth, slight increase in adjusted operating profit, decline in operating profitAnnual report
「Revenue was ¥618.0 billion, up 18.1% year on year. Adjusted operating profit increased 2.3% to ¥109.6 billion. Operating profit, profit before tax and quarterly profit attributable to owners of the parent all declined, affected by factors including the increase in amortization of acquired intangible assets, an adjustment item, due to the weaker yen.」
For the nine months ended December of FY2023, revenue increased 18.1% and adjusted operating profit increased 2.3%, while operating profit and other measures declined. Profit growth was limited relative to revenue growth, and the previous trend of “revenue growth and profit decline” continued in the form of a slight increase in adjusted operating profit and a decline in operating profit. - FY2023-Q2Continued sales growth and profit declineAnnual report
「Revenue was ¥403.3 billion, up 17.0% year on year. Operating profit declined as inflation drove up manufacturing costs. Adjusted operating profit fell 5.0% to ¥70.4 billion.」
In the six months ended September of FY2023, revenue increased 17.0% year on year, while adjusted operating profit fell 5.0% because of higher manufacturing costs due to inflation and the normalization of promotional activities. - FY2023-Q1Higher Revenue, Lower ProfitAnnual report
「Revenue was ¥197.3 billion, up 14.9% year on year.」
Revenue increased 14.9% year on year, while adjusted operating profit fell 10.7% because of inflationary pressure on manufacturing costs and the resumption of promotional activities. For sustainable, profitable growth, revenue growth and profit growth diverged. - FY2022Partial miss of the former targetAnnual report
「The business’s underlying growth potential was generally as expected, but the growth and profitability targets were missed because of lower demand resulting from repeated waves of COVID-19 infections since FY2020, adjustments to production volumes in response, and higher costs due to rising manufacturing and transportation expenses. The efficiency target, however, was achieved.」
The Company explained that, in the final year of the previous five-year growth strategy, it missed the targets for growth and profitability but achieved the efficiency target. - FY2022-Q3AdvancedAnnual report
「Revenue was ¥523.5 billion, up 16.7% year on year.」
For the nine months ended December of FY2022, revenue increased 16.7% year on year and adjusted operating profit increased 21.1%, with progress toward sustainable, profitable growth continuing. - FY2022-Q2AdvancedAnnual report
「Revenue was ¥344.6 billion, up 21.7% year on year. Adjusted operating profit increased 44.6% to ¥74.1 billion, as the increase in gross profit exceeded the increase in selling, general and administrative expenses.」
In the six months ended September of FY2022, revenue increased 21.7% year on year and adjusted operating profit increased 44.6%, marking a substantial improvement in progress toward sustainable, profitable growth. - FY2022-Q1AdvancedAnnual report
「Revenue was ¥171.7 billion, up 30.8% year on year.」
In FY2022-Q1, revenue increased 30.8% year on year, recovering from the decline in revenue in FY2021. Adjusted operating profit also increased 85.4% to ¥40.2 billion. - FY2021Full-Year Revenue and Profit DeclineAnnual report
「Consolidated revenue for the fiscal year was ¥613.8 billion, down 2.4% year on year, while operating profit was ¥98.4 billion, down 11.1%.」
In FY2021, both revenue and operating profit fell below the previous year, resulting in a full-year decline in performance related to sustainable, profitable growth. The Company explained, however, that it exceeded its initial profit forecasts in both FY2019 and FY2020. - FY2021-Q3Continued decline in cumulative resultsAnnual report
「Results for the nine months ended December were as follows. Revenue was ¥448.6 billion, down 4.6% year on year. Adjusted operating profit fell 10.1% to ¥88.5 billion, as the decline in gross profit outweighed efforts to partially restrain selling, general and administrative expenses.」
Against the backdrop of COVID-19, revenue for the nine months ended December fell 4.6% and adjusted operating profit fell 10.1%, with cumulative declines in revenue and profit continuing. - FY2021-Q2Partial recovery in deteriorating performanceAnnual report
「Demand recovered to some extent in July–September as some postponed procedures were performed. Revenue was ¥283.3 billion, down 7.8% year on year. Adjusted operating profit fell 23.5% to ¥51.3 billion, as the decline in gross profit outweighed efforts to partially restrain selling, general and administrative expenses.」
Following the sharp decline in revenue and profit in FY2021-Q1, demand recovered to some extent in July–September as some postponed procedures were performed. On a cumulative basis, however, revenue fell 7.8% and adjusted operating profit fell 23.5%, so the deterioration in performance continued. - FY2021-Q1Deteriorating performanceAnnual report
「Revenue was ¥131.3 billion, down 13.9% year on year. Adjusted operating profit fell 36.1% to ¥21.7 billion, as the decline in gross profit outweighed efforts to partially restrain selling, general and administrative expenses.」
Due to the spread of COVID-19, FY2021-Q1 revenue fell 13.9% year on year and adjusted operating profit fell 36.1%, marking a setback in performance related to sustainable, profitable growth. - FY2020AdvancedAnnual report
「Consolidated revenue for the fiscal year was ¥628.9 billion, up 4.9% year on year, while operating profit was ¥110.6 billion, up 3.7%.」
Heading into the fourth year of the five-year medium- to long-term growth strategy, FY2020 revenue increased 4.9%, operating profit increased 3.7% and adjusted operating profit increased 2.3%. Despite the impact of COVID-19, the full-year results demonstrated progress in growth and profitability. - FY2020-Q3AdvancedAnnual report
「Revenue was ¥470.1 billion, up 6.0% year on year.」
For the nine months ended December, revenue increased 6.0% year on year and adjusted operating profit increased 7.9%, demonstrating progress in sustainable, profitable growth. - FY2020-Q2AdvancedAnnual report
「Revenue was ¥307.3 billion, up 7.8% year on year.」
For the six months ended September, revenue increased 7.8% year on year and adjusted operating profit increased 21.2%, demonstrating progress in sustainable, profitable growth. - FY2020-Q1AdvancedAnnual report
「Revenue was ¥152.5 billion, up 6.6% year on year. Adjusted operating profit increased 11.1% to ¥33.9 billion, as the increase in gross profit absorbed higher selling, general and administrative expenses, including R&D expenses.」
In the first quarter, revenue increased 6.6% year on year and adjusted operating profit increased 11.1%, demonstrating quarterly progress toward the medium- to long-term policies for growth and profitability. - FY2019RestatedAnnual report
「Growth: grow faster than the pace of market expansion; revenue: high-single-digit growth / Profitability: profit growth faster than revenue growth; adjusted operating profit: double-digit growth; adjusted EPS: ¥135–150 / Efficiency: maintain an appropriate level of efficiency; adjusted ROE: maintain at least 10%」
The Company continues to state the targets of its five-year medium- to long-term growth strategy. After accounting for the stock split, the adjusted EPS target is stated as ¥135–150, with fiscal 2021 as the final year. - FY2019-Q3RestatedAnnual report
「Against this backdrop, the Group is pursuing management based on a medium- to long-term vision of becoming a manufacturer trusted worldwide as a leading brand in healthcare, while earning world-class trust in total quality, including products, supply and services, as a “global company originating in Japan.”」
The Company continues to pursue a medium- to long-term vision of earning trust in total quality and as a leading brand as a “global company originating in Japan.” - FY2019-Q2RestatedAnnual report
「Against this backdrop, the Group is pursuing management based on a medium- to long-term vision of becoming a manufacturer trusted worldwide as a leading brand in healthcare, while earning world-class trust in total quality, including products, supply and services, as a “global company originating in Japan.”」
The Company continues to pursue a medium- to long-term vision of earning trust in total quality and as a leading brand as a “global company originating in Japan.” - FY2018AdvancedAnnual report
「In the first year of the strategy, revenue and all profit measures reached record highs. Consolidated revenue for the fiscal year was ¥587.8 billion, up 14.3% year on year, while operating profit was ¥108.6 billion, up 23.7%.」
In the first year of the five-year medium- to long-term growth strategy, revenue and all profit measures reached record highs. Revenue increased 14.3% and operating profit increased 23.7%. - FY2018-Q3RestatedAnnual report
「Against this backdrop, the Group is pursuing management based on a medium- to long-term vision of becoming a manufacturer trusted worldwide as a leading brand in healthcare, while earning world-class trust in total quality, including products, supply and services, as a “global company originating in Japan.”」
The Company continues to pursue a medium- to long-term vision of earning trust in total quality as a “global company originating in Japan” and becoming a manufacturer trusted worldwide as a leading brand in healthcare. - FY2018-Q2RestatedAnnual report
「Against this backdrop, the Group is pursuing management based on a medium- to long-term vision of becoming a manufacturer trusted worldwide as a leading brand in healthcare, while earning world-class trust in total quality, including products, supply and services, as a “global company originating in Japan.”」
The Company continues to state its medium- to long-term vision of earning trust in total quality and as a leading brand as a “global company originating in Japan.” - FY2018-Q1ReframedAnnual report
「Against this backdrop, the Group is pursuing management based on a medium- to long-term vision of becoming a manufacturer trusted worldwide as a leading brand in healthcare, while earning world-class trust in total quality, including products, supply and services, as a “global company originating in Japan.”」
The Company has refined and reorganized the wording of its goal, moving from “becoming a globally prominent company” to a medium- to long-term vision of earning trust in total quality and as a leading brand as a “global company originating in Japan.” - FY2017ReframedAnnual report
「The Group formulated a medium- to long-term growth strategy covering the next five years, setting the following targets for growth, profitability and efficiency and working toward achieving them.」
The Company shifted from the previous medium-term management plan’s 20% target for operating margin before amortization of goodwill and other items to a framework of metrics under the five-year medium- to long-term growth strategy: high-single-digit revenue growth, double-digit growth in adjusted operating profit, adjusted EPS of ¥270–300 and adjusted ROE of at least 10%. - FY2017-Q3AdvancedAnnual report
「Looking 10 years ahead, the Group formulated in December a medium- to long-term growth strategy covering the five years beginning April 2017.」
Following the previous medium-term management plan, the Company formulated in December a five-year medium- to long-term growth strategy beginning in April 2017, with a 10-year outlook. - FY2017-Q2RestatedAnnual report
「Against this backdrop, the Group is currently pursuing management with company-based management as its core, under the goal of “becoming a globally prominent company,” and aims to achieve sustainable, profitable, high-quality growth.」
The Company continues to pursue the goal of “becoming a globally prominent company” and sustainable, profitable, high-quality growth. - FY2017-Q1RestatedAnnual report
「Against this backdrop, the Group is currently pursuing management with company-based management as its core, under the goal of “becoming a globally prominent company,” and aims to achieve sustainable, profitable, high-quality growth.」
The Company continues to state its goal of “becoming a globally prominent company” and its pursuit of sustainable, profitable growth centered on company-based management. - FY2016First statedAnnual report
「The Group is currently pursuing a four-year medium-term management plan ending with the fiscal year ending March 2017, under the goal of “becoming a globally prominent company.” The plan aims to achieve sustainable, profitable, high-quality growth, with a target operating margin before amortization of goodwill and other items of 20%.」
The medium-term management plan ending with the fiscal year ending March 2017, which set a target operating margin before amortization of goodwill and other items of 20%, was identified as the first instance. The actual result for the year was 19.4%, and the Company explained that it had “almost reached the target level one year ahead of schedule.”